Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
THERAPEUTIC USES FOR AMINOSTEROL COMPOUNDS
Document Type and Number:
WIPO Patent Application WO2002006299
Kind Code:
A3
Abstract:
A pharmaceutical composition includes, as an active ingredient, a compound according to formula 1436 as shown in Fig. 1, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or excipient. Various pharmaceutical products may be produced including this pharmaceutical composition. Such pharmaceutical products may be used for the treatment of atherosclerosis or the reduction of serum cholesterol.

More Like This:
JP2007530552Sequential SPRM / Progestin treatment
WO/2024/050864COMPOSITION FOR LOWERING BLOOD LIPIDS AND CHOLESTEROL, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
JP2000264820COMPOSITION FOR PROMOTING HAIR GROWTH
Inventors:
ZASLOFF MICHAEL
WILLIAMS JON
KINNEY WILLIAM
ANDERSON MARK
MCLANE MIKE
Application Number:
PCT/US2001/022078
Publication Date:
June 06, 2002
Filing Date:
July 13, 2001
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
GENAERA CORP (US)
International Classes:
A61K31/575; A61P3/06; A61P9/10; C07J41/00; (IPC1-7): A61K31/575; A61P3/06; A61P9/10
Domestic Patent References:
WO1996040728A21996-12-19
WO1996040151A11996-12-19
WO1997044044A11997-11-27
WO1998019682A11998-05-14
Other References:
ZASLOFF, M. ET AL: "A spermine-coupled cholesterol metabolite from the shark with potent appetite suppressant and antidiabetic properties", INTERNATIONAL JOURNAL OF OBESITY (2001), 25(5), 689-697, XP008001422
ZASLOFF, MICHAEL (1) ET AL: "A centrally acting cholesterol metabolite with potent appetite suppressan and antidiabetic properties.", PEDIATRIC RESEARCH, (APRIL, 2000) VOL. 47, NO. 4 PART 2, PP. 142A. MEETING INFO.: JOINT MEETING OF THE PEDIATRIC ACADEMIC SOCIETIES AND THE AMERICAN ACADEMY OF PEDIATRICS. BOSTON, MASSACHUSETTS, USA MAY 12-16, 200 AMERICAN ACADEMY OF PEDIATRICS., XP008001421
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: SOLUBLE IMMUNOGLOBULIN E RECEPTOR ALPHA LIKE MOLECULES

Next Patent: MUTATED PF-4, ITS FRAGMENTS AND MUTATED FUSION PEPTIDES, THEIR ANALOGUES, CORRESPONDING DNA, CDNA A...